Author:
Batista Elice Carneiro,Carvalho Luiz Roberto,Casarini Dulce Elena,Carmona Adriana Karaoglanovic,dos Santos Edson Lucas,da Silva Elton Dias,dos Santos Robson Augusto,Nakaie Clovis Ryuichi,Rojas Maria Verônica Munoz,de Oliveira Suzana Macedo,Bader Michael,D’Almeida Vânia,Martins Ana Maria,de Picoly Souza Kely,Pesquero João Bosco
Publisher
Springer Science and Business Media LLC
Subject
Genetics(clinical),Drug Discovery,Molecular Medicine
Reference48 articles.
1. Brady RO, Gal AE, Bradley RM, Martensson E, Warshaw AL, Lastes L (1967) Enzymatic defect in Fabry’s disease Ceramidetrihexosidase deficiency. N Engl J Med 276(21):1163–1167
2. Bloom D, Speijer D, Linthosrt GE, Donker-Koopman WG, Strijland A, Aerts JMFG (2003) Recombinant enzyme therapy for Fabry disease: absence of editing of human α-galactosidase A mRNA. Am J Hum Genet 72:23–31
3. Clarke TR (2007) Narrative review: Fabry disease. Ann Intern Med 146:425–433
4. Brady RO, Schiffmann R (2000) Clinical features of and recent advances in therapy for Fabry disease. Jama 284:2771–2775
5. Desnick RJ, Ioannou YA, Eng CM (2001) α-Galactosidase A deficiency: Fabry disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease, 8th edn. McGraw-Hill, New York, pp 3733–3774
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献